ACCF/AHA/ACP 2009 competence and training statement: a curriculum on prevention of cardiovascular disease.
American College of Cardiology Foundation et al.
J Am Coll Cardiol 2009;54:1336-1363.
FULL TEXT
ACCF/AHA/ACP 2009 Competence and Training Statement: A Curriculum on Prevention of Cardiovascular Disease: A Report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Competence and Training Statement on Prevention of Cardiovascular Disease): Developed in Collaboration With the American Academy of Neurology; American Association of Cardiovascular and Pulmonary Rehabilitation; American College of Preventive Medicine; American College of Sports Medicine; American Diabetes Association; American Society of Hypertension; Association of Black Cardiologists; Centers for Disease Control and Prevention; National Heart, Lung, and Blood Institute; National Lipid Association; and Preventive Cardiovascular Nurses Association
WRITING COMMITTEE MEMBERS et al.
Circulation 2009;120:e100-e126.
FULL TEXT
Association between prescription burden and medication adherence in patients initiating antihypertensive and lipid-lowering therapy
Benner et al.
Am J Health Syst Pharm 2009;66:1471-1477.
ABSTRACT
| FULL TEXT
Effectiveness of Valsartan for Treatment of Hypertension: Patient Profiling and Hierarchical Modeling of Determinants and Outcomes (the PREVIEW Study)
Van der Niepen et al.
The Annals of Pharmacotherapy 2009;43:849-861.
ABSTRACT
| FULL TEXT
Associations of Kidney Function with Cardiovascular Medication Use after Myocardial Infarction
Winkelmayer et al.
CJASN 2008;3:1415-1422.
ABSTRACT
| FULL TEXT
Beyond Established and Novel Risk Factors: Lifestyle Risk Factors for Cardiovascular Disease
Mozaffarian et al.
Circulation 2008;117:3031-3038.
FULL TEXT
Should We Be More Aggressive in the Therapy Against Cardiovascular Risk Factors?: Should we prescribe statin and aspirin for every diabetic patient, or is it time for a polypill?
Stirban and Tschoepe
Diabetes Care 2008;31:S226-S228.
ABSTRACT
| FULL TEXT
Maximising secondary prevention therapies in patients with coronary heart disease
Capewell and O'Flaherty
Heart 2008;94:8-9.
FULL TEXT
Improved Attainment of Blood Pressure and Cholesterol Goals Using Single-Pill Amlodipine/Atorvastatin in African Americans: The CAPABLE Trial
Flack et al.
Mayo Clin Proc. 2008;83:35-45.
ABSTRACT
| FULL TEXT
A Randomized, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, and Pharmacodynamic Interaction of Coadministered Amlodipine and Atorvastatin in 1660 Patients With Concomitant Hypertension and Dyslipidemia: The Respond Trial
Preston et al.
J Clin Pharmacol 2007;47:1555-1569.
ABSTRACT
| FULL TEXT
Factors Related to Adherence to Statin Therapy
McGinnis et al.
The Annals of Pharmacotherapy 2007;41:1805-1811.
ABSTRACT
| FULL TEXT
Will generic hypertension guidelines reduce the proliferation of directives?
Staessen and O'Brien
Heart 2007;93:775-777.
FULL TEXT
Physician Follow-up and Provider Continuity Are Associated With Long-term Medication Adherence: A Study of the Dynamics of Statin Use
Brookhart et al.
Arch Intern Med 2007;167:847-852.
ABSTRACT
| FULL TEXT
Low-Dose Quadruple Antihypertensive Combination: More Efficacious Than Individual Agents-A Preliminary Report
Mahmud and Feely
Hypertension 2007;49:272-275.
ABSTRACT
| FULL TEXT
Statins and the Risk of Lung, Breast, and Colorectal Cancer in the Elderly
Setoguchi et al.
Circulation 2007;115:27-33.
ABSTRACT
| FULL TEXT
Effect of a Pharmacy Care Program on Medication Adherence and Persistence, Blood Pressure, and Low-Density Lipoprotein Cholesterol: A Randomized Controlled Trial
Lee et al.
JAMA 2006;296:2563-2571.
ABSTRACT
| FULL TEXT
Bioavailability of amlodipine besylate/atorvastatin calcium combination tablet.
Chung et al.
J Clin Pharmacol 2006;46:1030-1037.
ABSTRACT
| FULL TEXT
Recommendations for Evaluating Compliance and Persistence With Hypertension Therapy Using Retrospective Data
Halpern et al.
Hypertension 2006;47:1039-1048.
FULL TEXT
Cost-Effectiveness of Fixed-Dose Combination of Isosorbide Dinitrate and Hydralazine Therapy for Blacks With Heart Failure
Angus et al.
Circulation 2005;112:3745-3753.
ABSTRACT
| FULL TEXT
Combination Pharmacotherapy for Cardiovascular Disease
Combination Pharmacotherapy and Public Health Rese
ANN INTERN MED 2005;143:593-599.
ABSTRACT
| FULL TEXT
Making Outpatient Care of Diabetes More Efficient: Analyzing Noncompliance
Leichter
Clin. Diabetes 2005;23:187-190.
FULL TEXT
Adherence to Concomitant BP- and Lipid-Lowering Therapies
Journal Watch Cardiology 2005;2005:4-4.
FULL TEXT